Crystal structure of streptavidin mutant with low immunogenicity-Reference-Cited by-同舟云学术

Crystal structure of streptavidin mutant with low immunogenicity

Published:2015-06 Issue:6 Volume:119 Page:642-647
ISSN:1389-1723
Container-title:Journal of Bioscience and Bioengineering
language:en
Short-container-title:Journal of Bioscience and Bioengineering

Author:

Kawato Tatsuya,Mizohata Eiichi,Meshizuka Tomohiro,Doi Hirofumi,Kawamura Takeshi,Matsumura Hiroyoshi,Yumura Kyohei,Tsumoto Kouhei,Kodama Tatsuhiko,Inoue Tsuyoshi,Sugiyama Akira

Funder

Cabinet Office, Government of Japan

Japan Society for the Promotion of Science

JST-ERATO

Grant-in-Aid for Scientific Research on Innovative Areas

X-ray Free-Electron Laser Priority Strategy Program

JSPS KAKENHI

Publisher

Elsevier BV

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Reference40 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int. J. Cancer,2010

2. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells;Lu;Leuk. Res.,2006

3. Development trends for monoclonal antibody cancer therapeutics;Reichert;Nat. Rev. Drug Discov.,2007

4. Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy;Goldenberg;J. Clin. Oncol.,2006

5. Pretargeted radioimmunotherapy of cancer: progress step by step;Boerman;J. Nucl. Med.,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of Vaterite Nanoparticles for Controlled Delivery of Active Immunotherapeutic Proteins;Particle & Particle Systems Characterization;2024-03-12

2. An Analysis of the Biotin–(Strept)avidin System in Immunoassays: Interference and Mitigation Strategies;Current Issues in Molecular Biology;2023-10-31

3. Multivalent protein-drug conjugates – An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells;Biotechnology Advances;2023-10

4. Sortase A transpeptidation produces seamless, unbranched biotinylated nanobodies for multivalent and multifunctional applications;Nanoscale Advances;2023

5. Antibody‐Incorporated Nanomedicines for Cancer Therapy;Advanced Materials;2022-04-24